Publication: Production and characterization of recombinant wild type uricase from indonesian coelacanth (L. menadoensis) and improvement of its thermostability by in silico rational design and disulphide bridges engineering
1
Issued Date
2019-03-02
Resource Type
ISSN
14220067
16616596
16616596
Other identifier(s)
2-s2.0-85062936275
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Molecular Sciences. Vol.20, No.6 (2019)
Suggested Citation
Sakda Yainoy, Thanawat Phuadraksa, Sineewanlaya Wichit, Maprang Sompoppokakul, Napat Songtawee, Virapong Prachayasittikul, Chartchalerm Isarankura-Na-Ayudhya Production and characterization of recombinant wild type uricase from indonesian coelacanth (L. menadoensis) and improvement of its thermostability by in silico rational design and disulphide bridges engineering. International Journal of Molecular Sciences. Vol.20, No.6 (2019). doi:10.3390/ijms20061269 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/50232
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Production and characterization of recombinant wild type uricase from indonesian coelacanth (L. menadoensis) and improvement of its thermostability by in silico rational design and disulphide bridges engineering
Other Contributor(s)
Abstract
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. The ideal therapeutic uricase (UOX) is expected to have the following properties; high expression level, high activity, high thermostability, high solubility and low immunogenicity. The latter property is believed to depend largely on sequence identity to the deduced human UOX (dH-UOX). Herein, we explored L. menadoensis uricase (LM-UOX) and found that it has 65% sequence identity to dH-UOX, 68% to the therapeutic chimeric porcine-baboon UOX (PBC) and 70% to the resurrected ancient mammal UOX. To study its biochemical properties, recombinant LM-UOX was produced in E. coli and purified to more than 95% homogeneity. The enzyme had specific activity up to 10.45 unit/mg, which was about 2-fold higher than that of the PBC. One-litre culture yielded purified protein up to 132 mg. Based on homology modelling, we successfully engineered I27C/N289C mutant, which was proven to contain inter-subunit disulphide bridges. The mutant had similar specific activity and production yield to that of wild type (WT) but its thermostability was dramatically improved. Up on storage at −20◦ C and 4◦ C, the mutant retained ~100% activity for at least 60 days. By keeping at 37◦ C, the mutant retained ~100% activity for 15 days, which was 120-fold longer than that of the wild type. Thus, the I27C/N289C mutant has potential to be developed for treatment of hyperuricemia.